Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis

被引:8
|
作者
Guo, Pengju [1 ]
Wang, Yongxing [1 ]
Han, Yili [1 ]
Wei, Dechao [1 ]
Zhao, Jiahui [1 ]
Li, Mingchuan [1 ]
Jiang, Yongguang [1 ]
Luo, Yong [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
renal tumor; pT3a; nephrectomy; cancer-specific survival; systematic review; PERINEPHRIC FAT INVASION; CELL CARCINOMA; PARTIAL NEPHRECTOMY; HIGH-RISK; SINUS FAT; PROGNOSTIC-SIGNIFICANCE; RADICAL NEPHRECTOMY; SIZE; IMPACT; SURVIVAL;
D O I
10.3389/fonc.2021.678459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features. Methods The protocol of this study was registered on PROSPERO (CRD42021234475). Relevant studies were identified by searching the PubMed, Cochrane library, Embase, and Web of Science databases. Cancer-specific survival (CSS) was selected as the endpoint. Pooled hazard ratio (HR) and 95% confidence interval (CI) extracted from multivariate Cox models were evaluated to identify the hazard association. Results A total of 22 studies, which enrolled 12384 patients were included for quantitative synthesis. Sinus fat invasion (SFI) + perinephric fat invasion (PFI) was associated with inferior CSS compared to SFI only (p = 0.02). Comparable CSS was observed between SFI and PFI (p = 0.57). SFI +/- PFI showed inferior CSS compared to PFI only (p = 0.0002). The presence of pelvicalyceal system invasion significantly increased the risk of cancer-specific mortality (p = 0.0005). Renal vein invasion (RVI) indicated poor oncological outcomes in terms of CSS (p = 0.002). The concomitant RVI and fat invasion (FI) significantly increased the risk of deterioration of CSS compared to RVI or FI (p < 0.0001). Multiple invasion patterns translated into a significantly decreased CSS (p < 0.0001). Aggressive tumor behavior, including lymph node involvement (p = 0.006), distant metastases (p < 0.00001), sarcomatoid differentiation (p < 0.0001), necrosis (p < 0.0001), Fuhrman grade III or IV (p < 0.0001), positive margin (p < 0.0001), and tumor size >7cm (p < 0.0001) were the predictors of inferior CSS. The lymphovascular invasion (p = 0.67) was indolent in terms of CSS. Conclusion This study confirmed the heterogenicity of pT3a renal tumors. Multiple invasion patterns could translate into a significantly decreased CSS, and SFI should not be merged in the SFI + PFI group. The presence of PSI or RVI could significantly increase the risk of cancer-specific mortality. Lymph node involvement, distant metastases, sarcomatoid differentiation, necrosis, high Fuhrman grade, positive margin, and size >7cm were the predictors of inferior CSS. A precise-risk grade of CSS for different invasion patterns including comprehensive combinations may be useful for the further refinements of the TNM system. Systematic Review Registration The current study was registered on PROSPERO, and the registration numbers is CRD42021234475.
引用
收藏
页数:13
相关论文
共 41 条
  • [1] Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors
    Karthikeyan, V. Senguttuvan
    Mallya, A.
    Sivaraman, A.
    Galiano, M.
    Rozet, F.
    Cathala, N.
    Barret, E.
    Mombet, A.
    Prapotnich, D.
    Sanchez-Salas, R.
    Cathelineau, X.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (05): : 234 - 240
  • [2] Impact of tumor diameter on prognosis in patients with renal cancer stage pT3a
    Bengio, Ruben G.
    Arribillaga, Leandro
    Montedoro, Ariel
    Bengio, Veronica
    Epelde, Javier
    Cordero, Esteban
    Onto, Hernon Garcia
    Bengio, Ruben H.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (05): : 480 - 485
  • [3] SURVIVAL OUTCOMES OF PT3A PATHOLOGICAL UPSTAGING IN PARTIAL VS. RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA
    Elshabrawy, Ahmed
    Wang, Hanzhang
    Dursun, Furkan
    Hemal, Ashok
    Porter, James
    Abaza, Ronney
    Eun, Daniel
    Stifelman, Michael
    Mansour, Ahmed M.
    Badani, Ketan
    JOURNAL OF UROLOGY, 2021, 206 : E780 - E780
  • [4] Clinical Outcomes of Patients with pT2b and Small Size pT3a Renal Cell Carcinomas Are Similar
    Zhong, H.
    Attwood, K.
    Huang, Y.
    Xu, B.
    LABORATORY INVESTIGATION, 2013, 93 : 261A - 262A
  • [5] Clinical Outcomes of Patients with pT2b and Small Size pT3a Renal Cell Carcinomas Are Similar
    Zhong, H.
    Attwood, K.
    Huang, Y.
    Xu, B.
    MODERN PATHOLOGY, 2013, 26 : 261A - 262A
  • [6] Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma
    Margulis, Vitaly
    Tamboli, Pheroze
    Matin, Surena F.
    Meisner, Matthew
    Swanson, David A.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2007, 178 (05): : 1878 - 1882
  • [7] Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors
    Veccia, Alessandro
    Falagario, Ugo
    Martini, Alberto
    Marchioni, Michele
    Antonelli, Alessandro
    Simeone, Claudio
    Cormio, Luigi
    Capitanio, Umberto
    Mir, M. Carmen
    Derweesh, Ithaar
    Van Poppel, Hendrik
    Porpiglia, Francesco
    Autorino, Riccardo
    EUROPEAN UROLOGY FOCUS, 2021, 7 (03): : 574 - 581
  • [8] Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors
    Pascal Mouracade
    Onder Kara
    Julien Dagenais
    M. J. Maurice
    R. J. Nelson
    Ercan Malkoc
    J. H. Kaouk
    World Journal of Urology, 2017, 35 : 1425 - 1433
  • [9] Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors
    Mouracade, Pascal
    Kara, Onder
    Dagenais, Julien
    Maurice, M. J.
    Nelson, R. J.
    Malkoc, Ercan
    Kaouk, J. H.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (09) : 1425 - 1433
  • [10] PERIOPERATIVE MORBIDITY, ONCOLOGICAL OUTCOMES AND PREDICTORS OF PT3A UPSTAGING FOR PATIENTS UNDERGOING PARTIAL NEPHRECTOMY FOR CT1 TUMORS
    Mouracade, Pascal
    Kara, Onder
    Dagenais, Julien
    Maurice, Matthew
    Nelson, Ryan
    Malkoc, Ercan
    Chavali, Jaya Sai
    Kaouk, Jihad
    JOURNAL OF UROLOGY, 2017, 197 (04): : E256 - E256